Effects of Repeated Oral Methamphetamine Administration in Humans
Overview
Affiliations
Rationale: Although methamphetamine use has increased over the past several years, few studies have evaluated the effects of repeated methamphetamine administration in humans.
Objectives: Because methamphetamine is often taken in a pattern of repeated use followed by a period of abstinence, the present study sought to evaluate the effects of repeated methamphetamine administration in humans. The hypothesis was that tolerance would develop to methamphetamine's effects.
Methods: Seven normal, healthy volunteers participated in a 15-day residential study. Participants completed subjective-effects questionnaires and psychomotor performance tasks repeatedly throughout the experimental day. Oral methamphetamine (5, 10 mg BID) was administered on days 4-6 and 10-12; placebo was administered on all other study days.
Results: Relative to placebo baseline, only two "positive" subjective ratings ("I feel a good drug effect" and "I feel high") were significantly elevated, and only on the 1st day of methamphetamine administration. In contrast, numerous "negative" ratings, including "I feel..." "a bad drug effect," "dizzy," and "flu-like symptoms" were elevated on the 3rd day of methamphetamine administration. Total caloric intake decreased and sleep was disrupted after methamphetamine administration, relative to baseline.
Conclusions: The pattern of methamphetamine's positive subjective effects were altered with chronic administration such that tolerance, or a decreased effect, occurred after repeated administration. In contrast, methamphetamine's negative subjective effects increased over days. These results suggest that in this population of normal volunteers, the abuse liability of oral methamphetamine is relatively low.
Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets.
Yates J Subst Abuse Rehabil. 2024; 15:125-161.
PMID: 39228432 PMC: 11370775. DOI: 10.2147/SAR.S431273.
Davis D, Metzger D, Vann P, Wong J, Shetty R, Forster M Psychopharmacology (Berl). 2023; 240(6):1343-1358.
PMID: 37127834 DOI: 10.1007/s00213-023-06374-y.
The Role of Non-coding RNAs in Methamphetamine-Induced Neurotoxicity.
Xu L, Li L, Chen Q, Huang Y, Chen X, Qiao D Cell Mol Neurobiol. 2023; 43(6):2415-2436.
PMID: 36752885 PMC: 11410138. DOI: 10.1007/s10571-023-01323-x.
Garrett T, Tulloch I, McCoy M, Ladenheim B, Jayanthi S, Krasnova I J Drug Alcohol Res. 2022; 1(1).
PMID: 36147517 PMC: 9491698. DOI: 10.4303/jdar/235626.
Allaeian Jahromi Z, Meshkibaf M, Naghdi M, Vahdati A, Makoolati Z ACS Omega. 2022; 7(6):5190-5196.
PMID: 35187334 PMC: 8851642. DOI: 10.1021/acsomega.1c06242.